Each month, MLO’s Editor in Chief, Christina Wichmann, interviews a lab leader. Meet five of our most recent lab innovators!
May 2025: Dr. Petra Furu, General Manager of Reproductive Health at Revvity explains newborn screening.
April 2025: Thomas P. Slavin Jr., MD, MBA, FACMGG, DABMD, Chief Clinical Officer, Molecular Oncology and Medical Director, Haystack Oncology at Quest Diagnostics discusses minimal residual disease (MRD) testing.
January 2025: Tamara Kirby, Laboratory and Quality Manager at Advanced Diagnostic Laboratory discusses implementing risk analysis into lab operations.
November 2024: Yves Dubaquie, PhD, SVP of Diagnostics at Revvity talks about automation’s role in transforming lab diagnostics.
August 2024: Cyril Verhille, BYG4lab talks about the company’s integration in the U.S. market.
